ArticlePharmaceuticals (Basel, Switzerland)2022

Long-Term Efficacy and Safety of Evinacumab in Patients with Homozygous Familial Hypercholesterolemia: Real-World Clinical Experience.

Claudia Stefanutti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.